Showing results (161-170 of 191) with videos related to
Sort By:
Pageof 20
American Journal of Hematology|July 1, 1990
Familial adult T-cell leukemia/lymphomaL Ratner, N Vander Heyden, E Paine, et al.Journal of Virology|October 12, 2000
Human T-lymphotropic virus type 1 open reading frame I p12(I) is required for efficient viral infectivity in primary lymphocytesB Albrecht, N D Collins, M T Burniston, et al.Virology|September 1, 1996
Sequence heterogeneity of Nef transcripts in HIV-1-infected subjects at different stages of diseaseL Ratner, T Joseph, J Bandres, et al.Proceedings of the National Academy of Sciences of the United States of America|March 15, 1991
Incorporation of 12-methoxydodecanoate into the human immunodeficiency virus 1 gag polyprotein precursor inhibits its proteolytic processing and virus production in a chronically infected human lymphoid cell lineM L Bryant, L Ratner, R J Duronio, et al.Journal of Virology|October 9, 1999
Proliferation response to interleukin-2 and Jak/Stat activation of T cells immortalized by human T-cell lymphotropic virus type 1 is independent of open reading frame I expressionN D Collins, C D'Souza, B Albrecht, et al.Molecular Immunology|October 1, 1995
Sera from HIV-1 infected individuals in all stages of disease preferentially recognize the V3 loop of the prototypic macrophage-tropic glycoprotein gp120 ADAC Ebenbichler, T McNearney, H Stoiber, et al.American Journal of Clinical Pathology|February 1, 1990
Immunoblastic lymphoma of T-cell type in a chronically immunosuppressed renal transplant recipientR C Griffith, B K Saha, C M Janney, et al.Khirurgiia|October 1, 1998
[20 years' experience of forced bouginage for cicatricial esophageal strictures]G L Ratner, V I Belokonev, A G Gabazov, et al.Journal of Virology|August 17, 2001
Sensitivity of human immunodeficiency virus type 1 to fusion inhibitors targeted to the gp41 first heptad repeat involves distinct regions of gp41 and is consistently modulated by gp120 interactions with the coreceptorC A Derdeyn, J M Decker, J N Sfakianos, et al.Science (New York, N.Y.)|August 8, 1986
Infectious mutants of HTLV-III with changes in the 3' region and markedly reduced cytopathic effectsA G Fisher, L Ratner, H Mitsuya, et al.Pageof 20